Sawai Pharmaceutical <4555.T>-2008/09 parent

May 11 (Reuters) -

SAWAI PHARMACEUTICAL CO LTD

PARENT-ONLY FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to

Mar 31, 2009 Mar 31, 2008 Mar 31, 2010

LATEST YEAR-AGO COMPANY

RESULTS RESULTS FORECASTS
Sales 43.04 36.27

(+18.7 pct) (+7.7 pct)
Operating 3.44 3.17

(+8.5 pct) (-10.7 pct)
Recurring 3.28 2.73

(+20.3 pct) (-15.9 pct)
Net 1.98 1.56

(+26.7 pct) (-9.9 pct)
EPS Y126.02 Y99.43
Annual div Y55.00 Y55.00 Y55.00
-Q2 div Y30.00 Y30.00 Y30.00
-Q4 div Y25.00 Y25.00 Y25.00

NOTE - Sawai Pharmaceutical Co Ltd is a medium-size pharmaceutical maker.

If there is no Q1 or Q3 dividend, Q2 will in most cases
correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed
companies to pay and report dividends on a quarterly basis.

For latest earnings estimates made by Toyo Keizai, please
double click on 4555.TK1.